The pharmaceutical industry is increasingly focused on developing drugs that mimic the brain's systems for maintaining wakefulness, with some experts comparing its potential impact to that of Ozempic.

An Eli Lilly executive, Patrik Jonsson, stated that obesity drugs are the hottest business in the pharmaceutical industry and predicted an end to obesity, while also criticizing Finland's current treatment approach.

Eli Lilly's weight-loss pill has successfully established its first market presence in Europe, marking a significant expansion for the pharmaceutical company.

An Indian start-up based in Bhubaneswar is conducting tests for drug manufacturing in space, exploring new frontiers for pharmaceutical production.

Analysts are evaluating whether Biohaven's recent deal with Regeneron Pharmaceuticals could serve as a major catalyst for its drug development pipeline.

Two 21-year-old pharmacy students, Mohini Gautre and Amruta Khedkar, drowned after falling into a dam while taking selfies and filming a reel on their mobile phones.

An oncology clinic in North Macedonia has announced seven new hires, including five nurses and two pharmaceutical technicians, to enhance its organizational and professional capacities.

The Nicolae Testemițanu State University of Medicine and Pharmacy in Moldova has published the final results of its admission competition for higher education and integrated studies, along with the number of available places for an additional enrollment session.

Switzerland's economic growth has significantly outpaced forecasts, largely propelled by strong performance in the pharmaceutical sector.

Startup Exobiosphere has secured €1 million in grant funding from Luxembourg's Ministry of Economy. Founded in 2024, the company is developing a space platform for biotechnology and pharmaceutical applications.

An analysis suggests that GSK plc's accelerated pipeline development could potentially usher in a new era of growth for the pharmaceutical company.

Several companies, including Biofrontera, Lamar Advertising, Frontdoor, and Peloton, have released their second-quarter 2026 earnings reports and corresponding call transcripts. These releases provide financial updates and insights into their performance.

A pharmacist from "Eurovaistinė" suggests the "20-20-20" rule to combat dry eye syndrome, often caused by computer screens, contact lenses, and dry environments.

Swiss pharmacies and doctors are refuting accusations of illegally pocketing two billion francs instead of returning them to premium payers, with the Federal Audit Office deeming the practice unlawful.

Remedica Limited is extending its voluntary recall of pharmaceutical products, initially announced on August 10, 2026, to cover two additional batches of Clonotril 2mg Tablets.

A woman has been arrested in Vienna for allegedly forging 85 medical prescriptions to illegally obtain medicines from pharmacies.

A Swiss pharmaceutical group has issued a warning that access to medicine is deteriorating, raising concerns about healthcare availability and equity.

A federal audit in Switzerland has revealed that hospitals are not consistently passing on discounts received from pharmaceutical companies and medical device manufacturers to patients, leading to higher healthcare costs for consumers.

A pharmacist in Jyväskylä, Finland, has decided to close their pharmacy due to a significant increase in property crimes, including aggravated robberies, which have risen by as much as a third.

Novartis Pharmaceuticals Corporation has issued a nationwide recall for certain heart failure and high blood pressure medications due to potency issues, as announced by the FDA.

A report by financial control reveals that doctors, hospitals, and pharmacists in Switzerland are collecting 360 million Swiss francs in drug discounts from pharmaceutical companies, which should rightfully belong to patients or health insurers. This practice is still widely considered a minor offense within the industry.

Protalix Pharmaceuticals indicated that its drug Elfabrio is on track to achieve a 15% to 20% market share in the Fabry disease treatment market by 2031, supported by its recent European approval for every-4-weeks administration.

An analysis explores the energy and pharmaceutical companies that are funding HDV's 3% yield, assessing the safety of each investment.

A list of pharmacies operating overnight across Cyprus on Wednesday, August 12, is provided, including specific locations and contact details for Nicosia and other areas.

Pharmaceutical giant Lilly has initiated legal action against six companies, accusing them of illegally selling its experimental obesity drug, retatrutide.

New Zealand's Pharmac agency announced that from September, individuals will be able to access up to three months' supply of a specific oestrogen patch brand at a time, simplifying the process for patients.

Hims & Hers, a telehealth company, is reportedly planning to expand its offerings by selling compounded peptides, signaling a move into new pharmaceutical products.

Many stores, museums, and institutions in Spain, particularly in Madrid, have run out of protective glasses, with only a few pharmacies still stocking them.

An analysis compares Eli Lilly and Company (LLY) and Novo Nordisk A/S (NVO) to determine which pharmaceutical giant is gaining an advantage in the rapidly expanding $100 billion obesity drug market.

Türkiye's pharmaceutical industry has experienced an over 8-fold increase in R&D spending between 2020 and 2024, positioning it as a leading sector in the region and Europe.

The morning-after pill is now available free of charge at local pharmacies in England, with nearly 305,000 doses provided through the new contraception service in its first five months.

A growing number of Swiss pharmaceutical companies are establishing operations in North Carolina, indicating a trend of international expansion and investment in the US market.

Rumors suggest British pharmaceutical giant AstraZeneca might pursue a merger with American competitor Bristol Myers Squibb, prompting commentary that such large-scale fusions often lead to failure.

Despite a recent setback with Amlitelimab, analysts suggest that the incident is unlikely to significantly impact Sanofi's multi-billion dollar pharmaceutical engine.

Financial commentator Jim Cramer has identified pharmaceutical giants like Johnson & Johnson (JNJ) and Eli Lilly (LLY) as strong investment opportunities. He highlights these companies as innovative plays outside the traditional technology sector.

Shares of Hikma Pharmaceuticals received a boost following a broker's decision to raise its price target for the company.

Jazz Pharmaceuticals is reportedly in the process of acquiring a company specializing in rare epilepsy drugs, in a deal potentially valued at $1.3 billion.

A summary of notable healthcare news for the week highlights developments concerning major pharmaceutical companies Eli Lilly, Novo Nordisk, and Pfizer.

The K-beauty retail landscape is evolving, with new beauty shops emerging to compete with established players like Olive Young, moving beyond traditional warehouse models towards pharmacy-style retail.

Pharmacist María José Salgado advises that understanding whether hair needs hydration or proteins is key to restoring it after summer damage from sun, salt water, chlorine, and heat.

Key highlights from Guardian Pharmacy Services' second-quarter earnings call are summarized, offering insights into the company's financial performance and business developments.

A pharmacy group reports that the amount of wasted medicines in England each year could fill 75 swimming pools, urging more regular reviews of repeat prescriptions.

NRx Pharma's stock saw an increase following the FDA's completion of its initial review for the company's ketamine product. This development marks a significant step for the pharmaceutical firm.

Verrica Pharmaceuticals has secured a $27.5 million nondilutive facility, aiming to extend its cash runway into 2028 as it anticipates top-line data from its COVE study by mid-2027.

Amazon Pharmacy is rolling out cheaper weight-loss drugs, including Ozempic, for as low as $50 a month for Medicare patients, aiming to make treatments more accessible.

The Nicolae Testemițanu State University of Medicine and Pharmacy in Moldova has announced that the submission of original documents for the higher education admission competition will take place from August 8-12.

Corvus Pharmaceuticals has outlined key milestones for its drug soquelitinib, including a PTCL futility analysis in Q1 2027 and Alzheimer's Disease (AD) topline data in Q3 2027.

The National Drug Law Enforcement Agency (NDLEA) and pharmacists in Edo State, Nigeria, are strengthening their partnership to combat drug abuse and illicit drug trafficking.

Apostolos Valtas addressed how the pharmaceutical market is impacted by international developments, rising production, energy, and transport costs, and discussed the operation of a new initiative concerning drug distribution.

Xenon Pharmaceuticals expects to submit its AZK New Drug Application later this quarter and has secured funding to support its operations until 2029.

The first academic chair dedicated to women in menopause has been established, with pharmacist Boticaria García involved in a joint project with the University of Granada. The initiative aims to generate rigorous yet practical knowledge on female health, exercise, and nutrition during menopause.

This article provides a summary of Collegium Pharmaceutical, Inc.'s earnings call for the second quarter of 2026.

Pharmaceutical giants Eli Lilly and Novo Nordisk have successfully defeated an antitrust lawsuit concerning their market position in GLP-1 drugs.

Artificial intelligence is proving to be a valuable accelerator in the discovery of new medications, significantly enhancing efficiency for major laboratories at all stages of developing innovative treatments.

The pharmaceutical industry is engaged in a competitive race to discover and develop the next major drug innovation for treating sleep disorders.

A Forbes article discusses the critical inflection point for AI in the pharmaceutical industry, highlighting five key lessons for Chief AI Officers, particularly emphasizing the non-negotiable aspect of compliance in regulated environments.

An investigation is underway in Trinidad and Tobago regarding how 365 pharmaceutical products were registered without proper oversight or knowledge.

Romania's National Agency for Medicines has temporarily blocked the sale of two series of Colebil and Panzcebil medicines in pharmacies, pending clarification of certain aspects.

Investment firm Antipodes has divested its holdings in pharmaceutical company Sanofi, citing a series of repeated setbacks in Sanofi's drug development pipeline as the reason for its exit.

This report provides a compilation of analyst estimates and ratings for Eli Lilly stock, offering insights into Wall Street's sentiment and price targets for the pharmaceutical company.

Reports of preliminary discussions between pharmaceutical giants AstraZeneca and Bristol Myers Squibb regarding a potential acquisition have been denied, clarifying earlier speculation over consolidation in the Big Pharma sector.

A pharmacy in Galway is moving to a new location next door, with its former premises slated to be converted into a family home.

Three contract workers died and two others were hospitalized following a toxic gas leak at a pharmaceutical manufacturing unit in Karnataka’s Yadgir district early Wednesday.

A pharmacist discusses the benefits of a specific product, with colleagues also highlighting its successful formula, suggesting it's a household essential.

Benzinga reports on the market sentiment for JIANGSU HENGRUI PHARMACEUTICALS CO LTD.

A 77-year-old retired pharmacist found his sister's body in her shop in Pekan Sungai Lalang, Sungai Petani, after checking in on her.

An analysis is being conducted to determine if the deal between BeOne Medicines AG (ONC) and Revolution Medicines (RVMD) represents a mutually beneficial outcome for both pharmaceutical companies.

Elite Pharmaceuticals has released highlights from its first-quarter earnings call, providing insights into the company's recent financial performance.

Pakistan's Minister of National Health Services urged the pharmaceutical industry to collaborate with the government to transform the country into an innovation and export hub, aiming for $10 billion in exports.

Two armed individuals stole a Rolex watch from a pharmacist in the 17th arrondissement of Paris on Thursday morning, prompting a police investigation.

Eton Pharmaceuticals saw its shares rise following a strong second-quarter earnings report and positive guidance for 2026.

The Swiss economy experienced surprisingly rapid growth in the second quarter, largely driven by the strong performance of its pharmaceutical sector. This growth exceeded forecasts, indicating robust economic activity.

The Jammu and Kashmir High Court has declared that access to safe medicines is a fundamental human right, not merely a consumer choice. This ruling emphasizes the importance of quality and safety in pharmaceutical products.

Singaporean pharmaceutical company iX Biopharma continued advancing its lead drug program after losing a key licensing partner, a persistence that opened new pathways to commercialization and unlocked value.

Several companies, including Talon Metals Corp., Nu Holdings, NUGL, BranchOut Food, Atrium Therapeutics, Camp4 Therapeutics, Tenon Medical, ARS Pharmaceuticals, Eledon Pharmaceuticals, Techprecision, and 4D Molecular Therapeutics, have released their second-quarter earnings reports, with varying results in EPS and revenue.

Portugal's National Pharmacovigilance System received 12,349 notifications of adverse drug reactions in 2025, a 9.2% increase from 2024, with 59.1% classified as serious.

Pharmaceutical Services urged patients not to discontinue their medication following a recall by Remedica, warning of serious health consequences if they do so.

An analysis delves into the broken economics behind high prescription drug prices in the United States, arguing that medicine will remain unaffordable if pricing is solely determined by pharmaceutical companies.

A 50-year-old woman has been charged with reckless driving after her car crashed into a pharmacy. The incident caused significant damage to the building.

A list of pharmacies operating overnight across Cyprus on Thursday, August 13, was published, including specific locations and contact details for Nicosia and other cities.

YIT Lietuva, a sustainable urban and infrastructure development company, announced that its 'Sky Office' business center in Vilnius has reached 100% occupancy, with technology and pharmaceutical companies securing the remaining spaces.

The Commission on Higher Education (CHED) has earmarked P56 million from the Higher Education Development Fund to provide financial aid to over 500 medical technology and pharmacy scholars for the upcoming academic semester.

Seoul's 120 Dasan Call Center will offer 24/7 information on hospitals, pharmacies, public transportation, and Han River park events during the Liberation Day holiday.

Atea Pharmaceuticals has outlined its potential to achieve over $700 million in peak annual U.S. net revenue, with a strategic focus on the launch of its HCV treatment in mid-2028.

Several companies, including SeaStar Medical, Leslie's, and Liftoff Mobile, have released their Q2 2026 earnings, with mixed results regarding EPS and revenue targets. Additionally, previews for Q2 2026 earnings were provided for Global Water Resources, MediWound, and Tecogen.

The Punjab and Haryana High Court has stayed the appointment process for pharmacy officer posts advertised by Baba Farid University of Health Sciences, Faridkot. The recruitment has been put on hold until a hearing scheduled for September 17 due to allegations of cheating.

More than 10,000 packages of the breast cancer drug tamoxifen are set to arrive in the Czech Republic, making the previously scarce medication available again in pharmacies. This delivery aims to alleviate the shortage of the crucial drug.

An article suggests that Revolution Medicines could become the next acquisition target for a major pharmaceutical company, highlighting its strategic value.

India's pharmaceutical exports increased by 6.8% to $8.1 billion in April-June FY27, with the US remaining the primary market, according to Pharmexcil data.

Representatives from the Romanian College of Pharmacists warn that the profession is losing its attractiveness among young people, leading to an increasing deficit of pharmacists and potential negative consequences for the country's healthcare system.

The National Centre for Pharmacoeconomics (NCPE) has stated that the cost of a drug for Friedreich's Ataxia must be reduced for the HSE to consider purchasing it.

A 35-year-old mason has been sentenced to eight years’ imprisonment by the Kwadaso Circuit Court in Ghana for robbing a pharmacist.

Eloxx Pharmaceuticals has announced its GAAP Earnings Per Share (EPS) at -$0.66, reflecting its financial performance for the recent period.

Partners of a pharmaceutical firm in Gujarat have been arrested for the illegal sale of codeine cough syrup.

An analysis compares Pfizer Inc. (PFE) and BioNTech SE (BNTX) to determine which pharmaceutical giant is better positioned for the market and healthcare landscape in the post-COVID era.

The Ministry of Economic Affairs and Communications proposes adding a post-implementation review clause to the pharmacy vending machine bill, assigning the Competition Authority to conduct the review.

Muitas lojas em Lisboa não conseguem repor stocks de óculos certificados para amanhã. Ainda neste jornal, as autoridades colombianas avisam que número de vítimas do sismo continua a aumentar.

A potential $400 billion merger between pharmaceutical giants AstraZeneca and Bristol Myers Squibb, which would have marked a return to mega-deals in the pharma sector, ultimately fell apart.

A bill aimed at overhauling India's drugs law is facing significant opposition from the pharmaceutical and medical device sectors, which claim their suggestions have not been accepted.

A pharmacist highlights a frequent error in the kitchen, especially during summer, where frozen food is left on the counter for hours to thaw, increasing the risk of food poisoning.

Tonix Pharmaceuticals has detailed its Phase II clinical trial for TNX-4800, which will involve approximately 3,300 participants, while also planning to scale its TONMYA sales force to about 150 representatives by September.

A competitor to pharmaceutical giant Novo Nordisk has received clearance to sell its weight-loss medication in the United Kingdom.

Hungarian authorities have ordered the immediate recall of a non-prescription drug from pharmacies, healthcare providers, and patients due to safety concerns.

The FDA is currently evaluating whether six experimental peptides should be made available through compounding pharmacies, with a decision pending on their authorization.

Relations between the Greek Ministry of Health and multinational pharmaceutical companies are at an impasse due to exorbitant mandatory clawback payments on hospital drugs and proposed legislative changes that are expected to exacerbate the issue.

An economic study on the impact of pharmaceutical innovation in Europe reinforces the argument that underinvestment in health does not lead to resource savings but ultimately costs more.

Unused medicines discarded in England in just one year could fill 75 swimming pools, according to the National Pharmacy Association (NPA). The association estimates 3,400 tons of partially used medicines are wasted.

Investments in pharmaceutical innovation, alongside mergers and acquisitions, are poised to define Europe's competitive edge and leadership in the industry for decades to come.

This article presents a summary of ANI Pharmaceuticals, Inc.'s second-quarter 2026 earnings call, covering key financial figures and business developments.

Hungarian pharmaceutical giant Gedeon Richter is expanding its global presence by entering the lucrative weight-loss drug market through an expanded strategic partnership with a Maltese pharmaceutical company.

Kiora Pharmaceuticals announced a GAAP EPS of -$0.34, surpassing analyst expectations by $0.28, as detailed in its latest financial report.

ANI Pharmaceuticals announced Non-GAAP EPS of $2.21, surpassing estimates by $0.17, and revenue of $266.04 million, beating forecasts by $5.91 million.

Nearly six thousand packages of tamoxifen, a drug used for hormonal treatment of breast cancer, are being distributed to Czech pharmacies, with further deliveries expected next week.

Nearly 6,000 packages of Tamoxifen, a crucial breast cancer medication, are being delivered to Czech pharmacies. The drug has been unavailable in the Czech Republic since last year after its manufacturer halted supplies.

Starting this month, insured individuals in North Macedonia will be able to obtain the medication 'Foster' from pharmacies only with a co-payment, as per the legally established participation fee for prescription services. This policy also applies to other medications containing the same active ingredients.

The key highlights from Novavax's second-quarter earnings call have been presented, detailing the pharmaceutical company's financial results and business developments.

New pharmaceutical developments are anticipated to drive fresh highs for stocks in the biotech and pharma sectors.

Gorenje, pharmaceutical companies, and energy traders are identified as the largest exporters in Slovenia. These sectors are significant contributors to the nation's export economy.

Guardian Pharmacy Services reported Q4 non-GAAP EPS of $0.29 and revenue of $351.8M, both surpassing analyst estimates. OmniAb also exceeded expectations with a GAAP EPS of -$0.05 and revenue of $13.4M for the fourth quarter.

Phio Pharmaceuticals announced its GAAP EPS of -$0.36, which was in line with analyst expectations for the quarter.

The National Organization for Medicines (EOF) in Greece held a comprehensive meeting to discuss the safety and distribution of pharmaceutical products, involving key officials and representatives.

The Food and Drug Administration (FDA) in India has revoked the license of the ayurvedic pharmaceutical company Inducare Pharma Pvt Ltd.

Francisco Carvalho Guerra, the first head of the Order of Pharmacists and responsible for founding and expanding the Catholic University of Porto, has died at the age of 93.

Medicare's decision to make weight-loss drugs available for $50 a month has ignited a race among pharmacies like Amazon, CVS, and Walmart to fill prescriptions, with Amazon offering significant discounts.

Krispy Kreme and Collegium Pharmaceutical have both released highlights from their respective second-quarter earnings calls. These summaries provide key financial updates from both companies.

Canaccord Genuity has reiterated its 'Buy' rating for ACADIA Pharmaceuticals (ACAD), signaling continued confidence in the company's stock.

Free solar eclipse glasses have sold out again, but alternatives are still available in pharmacies, science centers, supermarkets, and opticians across Portugal.

The Greek pharmaceutical industry, particularly in the Tripoli region, is planning a total investment of 1.8 billion Euros by 2028, aiming to position Greece as a key pharmaceutical production hub in Europe.

Celltrion's strong second-quarter results have led to numerous target-price upgrades from brokerages, with analysts citing the Korean biopharmaceutical company's expanding portfolio and improved profitability.

Vanda Pharmaceuticals Inc. conducted its Q2 2026 earnings call, detailing its financial outcomes and key developments during the second quarter.

Bargain Chemist in Lyall Bay, Wellington, is unable to fulfill prescriptions for funded medications and plans to appeal a decision by Health NZ.

Nouveau Life Pharmaceuticals, Inc. has released its financial report, providing an overview of the company's economic performance.

This article explores whether Keros Therapeutics (KROS)'s $20 million milestone from Takeda Pharmaceutical Company Limited (TAK) could unlock a billion-dollar opportunity for the company.

The potential for AbCellera Biologics (ABCL)'s deal with Vertex Pharmaceuticals Incorporated (VRTX) to transform its TCE platform into a breakthrough is being examined.

An article examines why Eton Pharmaceuticals is performing strongly today, highlighting factors contributing to its positive market position.

A pharmacist warns that a feeling of clogged ears after swimming could be the first sign of an ear infection, a common issue during the summer months.

A potential shortage of adrenaline pens is reported in Austria due to a strong wasp season, though a pharmaceutical company assures that multiple preparations are available for allergy sufferers.

Latvian pharmaceutical and medical goods distributor AS "Recipe Plus" has invested €20 million into establishing a new medical and pharmaceutical supply center in Riga.

Zentalis Pharmaceuticals experienced a decline in its stock value following the pricing of a public offering of 23 million shares at $3.50 per share.

Pharmacist and nutritionist María José Cachafeiro debunks common myths about nutrition, supplementation, and aging, addressing questions about collagen, microbiota, and the utility of supplements.

This article discusses the potential outcomes for AbbVie Inc. as Genmab A/S encounters a new regulatory challenge concerning their drug Epcoritamab. It analyzes the implications for both pharmaceutical companies.

A potential partnership between Merck & Co., Inc. (MRK) and Gilead Sciences, Inc. (GILD) is being explored as a possible new engine for growth in the pharmaceutical industry.

A fierce global battle is underway among European, American, and Chinese pharmaceutical companies to dominate the obesity treatment market. Novo Nordisk CEO Doustdar believes that no single player will monopolize this rapidly growing sector.

CorMedix presented its second-quarter earnings call, detailing financial results, strategic updates, and future outlook for the biopharmaceutical company.

Humana has agreed not to mention Teva Pharmaceutical Industries' ties to Israel during a US drug trial, a development in the ongoing legal proceedings.

Pulmatrix, a clinical-stage biopharmaceutical company, has reported a GAAP Earnings Per Share (EPS) of -$0.29.

A Swiss pharmaceutical group has reiterated its warning that access to new medicines is deteriorating, raising ongoing concerns about healthcare availability and equity.

A federal audit in Switzerland has revealed that hospitals are not consistently passing on discounts received from pharmaceutical companies and medical device manufacturers to patients. This failure means patients are paying more than they should for healthcare services.

Czech Health Minister Adam Vojtěch's proposal to allow pharmacists and dentists to administer flu vaccinations, aimed at increasing vaccination rates, has met resistance from both the medical chamber and a government colleague.

The first fully autonomous para-pharmacy in Europe has launched in Lisbon, operating 24/7 without staff and utilizing an AI-powered system for customer transactions.

Inovio Pharmaceuticals, Inc. has released its second-quarter 2026 earnings, with key highlights discussed during their recent earnings call. The company provided updates on its financial performance and operational progress for the quarter.

An analysis compares the VanEck Pharmaceutical ETF and the Invesco Biotech ETF to help investors determine which fund aligns with their investment style.

Acumen Pharmaceuticals announced its anticipation of a mid-2027 IND filing for its lead EBD candidate and confirmed that topline results for its Phase II ALTITUDE-AD trial are expected in late 2026.

Pharmaceutical companies in Greece will provide discounts on the prices of innovative medicines for adult obesity, which were distributed for free under a government program. The discounts will apply to the entire program, not just specific months.

New generic medications for diabetes are available, but an association warns that pharmacy shortages could force patients to pay more for brand-name drugs.

Teva Pharmaceuticals, a leading global manufacturer, reportedly does not want to emphasize its identity as an Israeli company in a lawsuit in the United States.

Vertex Pharmaceuticals' stock has rallied after Sionna Therapeutics' experimental cystic fibrosis drug failed in clinical trials. This outcome highlights the competitive landscape in drug development, where one company's setback can benefit another.

Multiple companies, including Pixelworks, Inuvo, and B&G Foods, have reported their Q2 2026 earnings, with some missing revenue or EPS estimates. Others, like Arq and Janus, provided revenue and adjusted EBITDA targets for 2026.

The pharmaceutical industry is increasingly focused on developing drugs that mimic the body's natural wakefulness systems, a trend some are comparing to the significant impact of Ozempic in its field.

Novo Nordisk has launched its new weekly insulin product in US pharmacies, making it available for patients. This development offers a new option for insulin management.

Back pain can sometimes indicate a serious underlying illness beyond muscle fatigue or spinal issues, and pharmacists advise understanding the cause of the pain is crucial for appropriate treatment.

A list of pharmacies operating overnight across Cyprus on Tuesday, August 11, has been released, including specific locations and contact details for Nicosia and other areas.

Basel's leading pharmaceutical hub is actively working to secure its position within the evolving global economic and political landscape.

The popular aperitif Bitter Kas was created by pharmacist Daniel Hausmann in Barcelona, who dedicated his life to researching medicinal plants and developing various formulas.

General Practitioners Aotearoa in New Zealand has voiced strong opposition to ACT's proposal to expand pharmacists' powers, viewing it as a warning sign for a struggling health system.

The last 24-hour pharmacy in Daugavpils, Latvia, has reduced its operating hours, leaving the entire Latgale region without any round-the-clock access to medicines. Pharmacists warn of a growing trend of reduced accessibility.

Protagonist Therapeutics received an upgrade from Goldman Sachs, citing the potential of its autoimmune asset. This financial news highlights investor confidence in the company's pharmaceutical developments.

A list of pharmacies operating during the night across Cyprus on Monday, August 10, including specific locations and contact details for Nicosia.

A pharmacist advises on proper facial cleansing, explaining that feeling tightness after washing indicates incorrect practices and that even good cosmetics won't work without the right cleanser.

The Czech Medical Chamber has proposed that pharmacies should only sell flu medicines containing pseudoephedrine by prescription. This recommendation aims to regulate access to these medications.

Private pharmacies recorded an increase in sales in 2025, with 73% attributed to medicines and 27% to parapharmaceutical products. Estimates for 2026 predict a continued upward trend in sales.

A pharmacist has highlighted a sign indicating a treacherous disease for those suffering from headaches in summer, noting that changes in lifestyle and habits during the summer can influence the frequency of migraine attacks.

Major global pharmaceutical companies are significantly increasing their investments in China's rapidly expanding biotech sector, citing its substantial potential for innovation and valuation growth.

A US judge has temporarily blocked the Defense Department from enforcing its designation of WuXi AppTec Co. as a Chinese military company. This grants temporary relief to the major pharmaceutical contractor amidst ongoing scrutiny.

This article provides a summary of the key points from Xenon Pharmaceuticals' second-quarter earnings call.

International Cat Day on August 8th prompts reflection on beloved pets and the plight of homeless cats, with a retail chain and veterinary pharmacy network launching a campaign to support them.

A nationwide system error that prevented pharmacies across Norway from dispensing prescriptions has been corrected, though the fix took longer than initially expected.

Morgan Stanley has shifted its stance to positive on Roche, citing building momentum in the pharmaceutical company's pipeline of new drugs and treatments.

Hungarian pharmaceutical company Richter Gedeon is moving its active ingredient production from Budapest to Dorog, a decision linked to previous workforce reductions and restructuring.

European equities saw an uptick at the start of trading today, with the pan-European STOXX 600 index rising by 0.2%. The pharmaceutical sector recorded the most significant gains.

The Greek pharmaceutical market, encompassing both manufacturing and import companies, shows significant interest with increased turnover and more than doubled net profits. The prospects for the Greek pharmaceutical industry are positive.

Two widely used medicines, Colebil and Panzcebil, produced by Biofarm, have been preventively withdrawn from pharmacies in Romania. The measure is temporary, pending clarification regarding the substance manufacturer.

China's pharmaceutical industry is grappling with a severe shortage and soaring prices of lab monkeys, with cynomolgus macaques doubling in cost within a year, making securing research primates as challenging as negotiating for Nvidia chips.

A warehouse in Lagos, Nigeria, was found to be repackaging suspected fake drugs, including Viagra and Omeprazole, raising concerns about counterfeit pharmaceuticals.

This article provides a summary of Ligand Pharmaceuticals Incorporated's earnings call for the second quarter of fiscal year 2026.

BioMarin Pharmaceutical's earnings report is anticipated as its key drug faces increasing competition in the market.

Analysts have offered their insights and ratings on healthcare companies Vertex Pharmaceuticals (VRTX) and Q32 Bio (QTTB).

Teva Pharmaceuticals is seeking to prevent its ties to Israel from being presented to a jury, citing the ongoing Gaza war. The company argues that this information could prejudice the jury.

Amylyx Pharmaceuticals provided highlights from its Q2 earnings call, outlining key financial results and updates on its pharmaceutical pipeline.

West Pharmaceuticals (WST) announced that it experienced broad-based growth during the second quarter of the fiscal year.

Novo Nordisk, which became Europe's most valuable company thanks to its weight loss drug Wegovy, is now reportedly struggling to identify its next major blockbuster pharmaceutical.

The Globe and Mail highlights analysts' insights on healthcare companies such as Ionis Pharmaceuticals (IONS), Oculis Holding (OCS), and CervoMed (CRVO).

The Union health and family welfare ministry in India has amended rules to debar pharmaceutical firms found submitting fake or fabricated data, a move aimed at strengthening the integrity of the regulatory system.

Thanasis Mouchtis, General Manager of PEI.FA.SYN., discussed future trends in the pharmaceutical wholesale sector, anticipating a landscape with fewer companies but stronger players.

Mirum Pharmaceuticals is targeting $680 million to $700 million in sales for 2026, as its PSC NDA submission has been shifted to the first half of next year.